Cleared Traditional

K221075 - Infusion Sets for Single Use

K221075 is an FDA 510(k) clearance for Infusion Sets for Single Use, manufactured by Sichuan Prius Biotechnology Co., Ltd.. The device is a Class 2 General Hospital device with product code FPA cleared through the Traditional 510(k) pathway after a 223-day FDA review.

K221075 · Sichuan Prius Biotechnology Co., Ltd. · General Hospital
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2022
Decision
223d
Days
Class 2
Risk

K221075 is an FDA 510(k) clearance for the Infusion Sets for Single Use. Classified as Set, Administration, Intravascular (product code FPA), Class II - Special Controls.

Submitted by Sichuan Prius Biotechnology Co., Ltd. (Yibin, CN). The FDA issued a Cleared decision on November 21, 2022 after a review of 223 days - an extended review cycle.

This device falls under the General Hospital FDA review panel, regulated under 21 CFR 880.5440 - the FDA general hospital device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the General Hospital review framework, consistent with the majority of Class II 510(k) submissions.

View all Sichuan Prius Biotechnology Co., Ltd. devices

FDA 510(k) Submission Details - K221075

510(k) Number K221075 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 12, 2022
Decision Date November 21, 2022
Days to Decision 223 days
Submission Type Traditional
Review Panel General Hospital (HO)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
94d slower than avg
Panel avg: 129d · This submission: 223d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

FPA Device Classification - Class 2, Special Controls

Product Code FPA Set, Administration, Intravascular
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 880.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most General Hospital devices follow this clearance model.

Regulatory Consultant

Mid-Link Consulting Co, Ltd.
Diana Hong

The regulatory consultant manages the 510(k) submission process on behalf of the applicant - coordinating technical documentation, predicate strategy and FDA communications. Identifying the consultant behind a submission is a key signal for competitive regulatory intelligence.

Regulatory Peers - FPA Set, Administration, Intravascular

All 532
Devices cleared under the same product code (FPA) and FDA review panel - the closest regulatory comparables to K221075.
BD SmartSite™ Needle-Free Connector
K223088 · Care Fusion · Apr 2023
FlowArt® Needle-Free Split Septum Valve
K222889 · Asset Medikal Tasarim San Tic As. · Jan 2023
Infusion Sets for Single Use with Needles
K221069 · Sichuan Prius Biotechnology Co., Ltd. · Nov 2022
Intravenous Needles for Single Use,Safety Intravenous Needles for Single Use
K221078 · Sichuan Prius Biotechnology Co., Ltd. · Nov 2022
NP Medical nCompass Extension Set with Stabilizing Base
K221518 · Np Medical · Nov 2022
AMSafe NeuFlo Needleless Connector
K220267 · Amsino International, Inc. · Oct 2022